Rabinder K. Prinjha
GlaxoSmithKline R&D
Stevenage, ENG, United Kingdom
Stevenage, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The signaling cascade of induction and maintenance of ES cell diapause.
Journal: Research square
Published: September 16, 2024
CBP/P300 Inhibition Impairs CD4+ T Cell Activation: Implications for Autoimmune Disorders.
Journal: Biomedicines
Published: April 24, 2024
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Journal: British journal of clinical pharmacology
Published: April 30, 2021
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis.
Journal: Journal of Crohn's & colitis
Published: October 02, 2020
Signaling function of PRC2 is essential for TCR-driven T cell responses.
Journal: The Journal of experimental medicine
Published: January 12, 2017
Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Journal: Human molecular genetics
Published: March 27, 2014
The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.
Journal: ACS chemical biology
Published: February 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026